Español
English
Français
Deutsch
Italiano
- Autor:
- Eduardo Anitua
- Ronald M Sanchez-Avila
- Edmar E Uribe-Badillo
- Javier Fernández-Vega Sanz
- Francisco Muruzabal
- Nancy Jurado
- Belén Alfonso-Bartolozzi
- Jose F Alfonso
- Begoña Baamonde
- Jesus Merayo-Lloves
Plasma rich in growth factors versus Mitomycin C in photorefractive keratectomy
Medicine (Baltimore). 2021 Jan 22;100(3):e24139. To evaluate the efficacy and safety of plasma rich in growth factors (PRGF) in photorefractive keratectomy (PRK) versus Mitomycin C (MMC).This is a comparative, longitudinal and retrospective case-control study (MMC vs PRGF), in patients with a spherical correction from -0.25 to -8.00 D and cylinder correction from -0.25 to -3.00
- Autor:
- Eduardo Anitua
- Sabino Padilla
- Mikel Sánchez
- Victor Vaquerizo
- Gerard A Malanga
- Nicolás Fiz
- Juan Azofra
- Christopher J Rogers
- Gonzalo Samitier
- Steven Sampson
- Roberto Seijas
- Ricardo Elorriaga
- Jack Taunton
- Frank Boehm
- Roberto Prado
- Ramón Cugat
Platelet-Rich Plasma Applications for Achilles Tendon Repair: A Bridge between Biology and Surgery
Int J Mol Sci. 2021 Jan 15;22(2):824. Achilles tendon ruptures are very common tendon ruptures and their incidence is increasing in modern society, resulting in work incapacity and months off sport, which generate a need for accelerated and successful therapeutic repair strategy. Platelet-rich plasma (PRP) is emerging as adjuvant human blood-derived constructs to assist Achilles tendon rupture treatment
- Autor:
- Eduardo Anitua
- María de la Fuente
- Francisco Muruzábal
- Jesús Merayo-Lloves
Short- and Long-Term Stability of Plasma Rich in Growth Factors Eye Drops
Cornea. 2021 Jan;40(1):107-112. To analyze whether plasma rich in growth factors (PRGFs) eye drops preserve their activity and biological properties after storage for 9 and 12 months at -20°C, and at 4°C, and at room temperature (RT) for 3 and 7 days in comparison to fresh samples (t0)
- Autor:
- Eduardo Anitua
- Mohammad H. Alkhraisat
- Sofía Fernández de Retana
Platelet rich plasma in oral and maxillofacial surgery from the perspective of composition
Platelets. 2021 Feb 17;32(2):174-182. The application of platelet-rich plasma (PRP) in oral and maxillofacial surgery has been thoroughly studied in the last two decades. Currently, different types of PRP are applied in the clinical practice, being the presence or absence of leukocytes one of the classification criteria. However, there is poor evidence assessing the influence of the PRP composition in their efficacy.
- Autor:
- Eduardo Anitua
- Suárez-Barrio C
- Del Olmo-Aguado S
- García-Pérez E
- Artime E
- de la Fuente M
- Muruzabal F
- Baamonde-Arbaiza B
- Fernández-Vega L
- Merayo-Lloves J.
Plasma Rich in Growth Factors Enhances Cell Survival after in Situ Retinal Degeneration
Int J Mol Sci. 2020 Oct 9;21(20):7442. The purpose of this study was to examine the effect of plasma rich in growth factors (PRGFs) under blue light conditions in an in vivo model of retinal degeneration.
- Autor:
- Eduardo Anitua
- de la Fuente M
- Del Olmo-Aguado S
- Suarez-Barrio C
- Merayo-Lloves J
- Muruzabal F.
Plasma rich in growth factors reduces blue light-induced oxidative damage on retinal pigment epithelial cells and restores their homeostasis by modulating vascular endothelial growth factor and pigment epithelium-derived factor expression
Clin Exp Ophthalmol. 2020 Aug;48(6):830-838. This study analysed the effectiveness of plasma rich in growth factors (PRGF) in reducing the oxidative stress induced by blue light exposition on retinal pigment epithelial (RPE) cells.
- Autor:
- Eduardo Anitua
- Suárez-Barrio C
- Del Olmo-Aguado S
- García-Pérez E
- de la Fuente M
- Muruzabal F
- Baamonde-Arbaiza B
- Fernández-Vega-Cueto L
- Fernández-Vega L
- Merayo-Lloves J.
Antioxidant Role of PRGF on RPE Cells after Blue Light Insult as a Therapy for Neurodegenerative Diseases
Int J Mol Sci. 2020 Feb 4;21(3):1021. Oxidative stress has a strong impact on the development of retinal diseases such as age-related macular degeneration (AMD). Plasma rich in growth factors (PRGF) is a novel therapeutic approach in ophthalmological pathologies. The aim of this study was to analyze the antioxidant effect of PRGF in retinal epithelial cells (EPR) in in vitro and ex vivo retinal phototoxicity models. In vitro analyses were performed on ARPE19 human cell line. Viability and mitochondrial status were assessed in order to test the primary effects of PRGF.
- Autor:
- Sánchez-Ávila RM
- Fernández-Vega González Á
- Fernández-Vega Sanz Á
- Merayo-Lloves J
Treatment of recurrent myopic macular hole using membrane of plasma rich in growth factors
Int Med Case Rep J. 2019 Jul 12;12:229-233. To describe the case of a patient with a recurrent large myopic macular hole (MH), who was successfully treated with a plasma rich in growth factors (PRGF) membrane.
- Autor:
- E. Bezuglov
- N. Maffulli
- A. Tokareva
- E. Achkasov
Platelet-rich plasma in hamstring muscle injuries in professional soccer players. A pilot study
Muscles, Ligaments and Tendons Journal 2019;9 (1) This study evaluated the efficacy of a single injection of Platelet-rich plasma (PRP) in the management of hamstring injuries (grade 2a and 2b according to the British Athletics Muscle Injury Classification) in professional soccer players.
- Autor:
- Eduardo Anitua
- Muruzábal F
- Riestra A
- De la Fuente M
- Merayo-Lloves J
Galenic validation of plasma rich in growth factors eye drops
Farm Hosp. 2019 Mar 1;43(2):45-49. Galenic evaluation of the process for obtaining and storing the platelet rich in growth factors PRGF-Endoret® eye drops.